Intragastric Balloon Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Intragastric Balloon Market
The intragastric balloon market size was valued at USD 39.2 million in 2022, and the market is now projected to grow from USD 44.5 million in 2023 to USD 110.9 million by 2030, exhibiting a CAGR of 13.9% during the forecast period of 2023-2030.
The impositions of stringent lockdown and stoppage on traveling have affected the market significantly. The COVID-19 pandemic caused hindrance for the intragastric balloon market growth. The drop in patient visits have declined in weight-loss procedures as a result it has reduced demand for the product. The temporary halt in elective surgeries amid the pandemic affected the market adversely. The companies operating in the market also witnessed a fall in their financial position that has halted the production of the item.
The intragastric balloon market share globally has increased because of the rising incidence of obesity. This is a growing difficulty associated with bariatric operation and as a result, they are propelling demand for the tool. It is the reason for numerous chronic disorders involving hypertension and diabetes that are attracting individuals for utilization of the product. The people in developed and metropolitan areas are shifting their living way towards a sedentary lifestyle. Additionally, less physical activities, is prompting a high burden of fatness among the population in the world. The growing complications associated with bariatric surgeries, are raising the demand for safe and efficient products amongst patients.
The trend is changing inclination towards swallowable gastric balloon capsules is boosting the market growth. The rising rate of obesity and related complications is aiding demand for less intricate weight loss procedures. In order to meet the growing demand for a not detrimental and effective treatment is supporting the market growth. The manufacturers are changing their focus to adopt the balloon capsules. These capsules can be administered orally devoid of any endoscopic procedure, surgery, and anesthesia.
Comprehensive Analysis of Intragastric Balloon Market
The intragastric balloon market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessment considering the dominant supply and demand forces that impact the healthcare industry. These segmentations are methodically segregated by types of product type, administration, filling material, and end-user. The product type is such as single, dual, and triple whereas; administration includes pill and endoscopy. The filling materials are saline-filled and gas-filled; on the other hand, the end-users are hospitals & clinics, outpatient surgical centers, and others.
The North American region is conducive to the global intragastric balloon market, leading to a recall of USD 16.4 billion owing to growing prevalence of obesity and shifting preference toward technologically advanced products is one of the prime aspects for enhancing the market expansion in this region.
The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include Allurion Technologies, Inc. (U.S.), Apollo Endosurgery Inc. (U.S.), ReShape Lifesciences, Inc. (U.S.), Spatz Medical (U.S.), Lexel SRL (Argentina), Medispar NV (Belgium), Endalis (France), Districlass Medical (France), Silimed Brazil (Brazil), and Suzhou Shenyun Medical Equipment Co., Ltd (China), these market players provide a level-playing competitive landscape.
In October 2023, Allurion completed patient enrollment in its AUDACITY trial. The study is a pivotal controlled trial designed to support the U.S. FDA approval of the gastric balloon made by the company.
Segmentation Table
Global Intragastric Balloon Market Scope
ATTRIBUTE DETAILS
Study Period 2017-2030
Base Year 2022
Estimated Year 2023
Forecast Period 2023-2030
Historical Period 2017-2021
Growth Rate CAGR of 13.9% from 2023-2030
Unit Value (USD Million)
Segmentation By Product Type
Single
Dual
Triple
By Administration
Pill
Endoscopy
By Filling Material
Saline-Filled
Gas-Filled
By End-user
Hospitals & Clinics
Outpatient Surgical Centers
Others
By Region
North America (By Product Type, Administration, Filling Material, End-user, and Country)
U.S.
Canada
Europe (By Product Type, Administration, Filling Material, End-user, and Country/Sub-region)
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific (By Product Type, Administration, Filling Material, End-user, and Country/Sub-region)
China
India
Japan
Rest of the Asia Pacific
Rest of the World (By Product Type, Administration, Filling Material, and End-user)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.